A Study of the Immune Response to Heplisav in Healthy Older Adults
Clinical trial NCT01999699 · COMPLETED
Trial details
- NCT number
- NCT01999699
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-02-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.